PharmaTelevision - IDA Ireland: Dave Shanahan explains the reasons for Ireland's remarkable impact in pharmaceutical space

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: IDA Ireland: Dave Shanahan explains the reasons for Ireland's remarkable impact in pharmaceutical space

Visitors: You are watching a 30 seconds preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharnaTelevision News Review, Fintan Walton talks to Dave Shanahan, Global Head of Life Sciences of IDA Ireland

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Reasons for Ireland's remarkable impact in pharmaceutical space

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here at BIO 2011 in Washington. On this show I have Dave Shanahan, who is Global Head of Lifesciences at the Irish IDA , welcome to the show.

Dave Shanahan:

Thank you very much indeed Fintan.

Fintan Walton:

Tell us what the IDA in Ireland actually does?

Dave Shanahan:

So IDA is the government's investment and development agency, we are responsible for attracting foreign direct investment into Ireland with a long track record since the 60's of going all over the world and discussing with multinationals why Ireland is a great value proposition for companies to come and locate to.

Fintan Walton:

Okay, now obviously we are here at BIO here in Washington you are here obviously as a representative of the life sciences interest of Ireland, but one of the areas that Ireland I suppose has made a remarkable impact is in the pharmaceutical space, could you tell us why that is the case?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Fintan Walton

Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).

Dave Shanahan

Global Head

Dave Shanahan currently serves as Global Head of Lifesciences at the Irish IDA. Dave Shanahan is a science graduate of university College Cork and a business graduate of Trinity College Dublin. He has worked for 22 years in Ireland's healthcare Industry, 20 years spent in Pharmaceuticals where he previously worked for J&J, ICI, Zeneca including 7 years as Country Manager Pfizer Healthcare Ireland. He was also CEO of Charter Medical Group a healthcare startup and has consulted for a number of Biotech and Pharma companies. He joined IDA Ireland as Global Head of Lifesciences in July 2009, responsible for IDA's global team working to attract further multinational investment to Ireland in the areas of Pharma, Biopharmaceuticals, Medical Technologies and Devices, Food and Healthcare Services.

PharmaVentures

PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.

IDA Ireland

IDA has national responsibility for securing new investment from overseas in manufacturing and international services sectors and for encouraging existing foreign enterprises in Ireland to expand their businesses. The businesses which IDA seeks to win are internationally mobile projects which can operate competitively and profitably from Ireland. This covers a range of sectors such as electronics, pharmaceuticals and health care, engineering and international and financial services. IDA Ireland markets this country as an attractive location for overseas investment through its network of offices abroad, emphasizing the stability and growing competitiveness of the Irish economy, the favorable tax regime, financial incentives, the outstanding skills base and our active participation in the new Europe.